Education
About Us
Working with TipRanks
Follow Us
EKF Diagnostics Holdings PLC (GB:EKF)
LSE:EKF
Total Valuation
EKF Diagnostics Holdings has a market cap or net worth of £136.97M. The enterprise value is 106.78M.
Market Cap£136.97M
Enterprise Value106.78M
Share Statistics
EKF Diagnostics Holdings has 449,093,780 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding449,093,780
Owned by Insiders29.91%
Owned by Institutions―
Financial Efficiency
EKF Diagnostics Holdings’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 8.91%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)8.91%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee165.66K
Profits Per Employee20.60K
Employee Count303
Asset Turnover0.61
Inventory Turnover3.88
Valuation Ratios
The current PE Ratio of EKF Diagnostics Holdings is 21.3. EKF Diagnostics Holdings’s PEG ratio is 0.12.
PE Ratio21.3
PS Ratio2.44
PB Ratio1.69
Price to Fair Value1.69
Price to FCF10.74
Price to Operating Cash Flow9.93
PEG Ratio0.12
Income Statement
In the last 12 months, EKF Diagnostics Holdings had revenue of 50.19M and earned 6.24M in profits. Earnings per share was 0.01.
Revenue50.19M
Gross Profit21.48M
Operating Income6.46M
Pretax Income6.26M
Net Income6.24M
EBITDA11.16M
Earnings Per Share (EPS)0.01
Cash Flow
In the last 12 months, operating cash flow was 10.71M and capital expenditures -1.24M, giving a free cash flow of 9.47M billion.
Operating Cash Flow10.71M
Free Cash Flow9.47M
Free Cash Flow per Share0.02
Dividends & Yields
EKF Diagnostics Holdings pays an annual dividend of 1.2p, resulting in a dividend yield of 4.8%
Dividend Per Share1.2p
Dividend Yield4.8%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.18
52-Week Price Change-6.49%
50-Day Moving Average29.53
200-Day Moving Average25.66
Relative Strength Index (RSI)44.09
Average Volume (3m)613.24K
Important Dates
EKF Diagnostics Holdings upcoming earnings date is Mar 31, 2026, TBA (Confirmed).
Last Earnings DateSep 16, 2025
Next Earnings DateMar 31, 2026
Ex-Dividend DateNov 02, 2023
Financial Position
EKF Diagnostics Holdings as a current ratio of 4.44, with Debt / Equity ratio of 1.82%
Current Ratio4.44
Quick Ratio3.29
Debt to Market Cap<0.01
Net Debt to EBITDA-1.16
Interest Coverage Ratio37.77
Taxes
In the past 12 months, EKF Diagnostics Holdings has paid -314.00K in taxes.
Income Tax-314.00K
Effective Tax Rate-0.05
Enterprise Valuation
EKF Diagnostics Holdings EV to EBITDA ratio is 9.82, with an EV/FCF ratio of 9.60.
EV to Sales2.18
EV to EBITDA9.82
EV to Free Cash Flow9.60
EV to Operating Cash Flow8.02
Balance Sheet
EKF Diagnostics Holdings has £16.62M in cash and marketable securities with £1.12M in debt, giving a net cash position of £15.49M billion.
Cash & Marketable Securities£16.62M
Total Debt£1.12M
Net Cash£15.49M
Net Cash Per Share£0.03
Tangible Book Value Per Share£0.10
Margins
Gross margin is 48.60%, with operating margin of 12.87%, and net profit margin of 12.44%.
Gross Margin48.60%
Operating Margin12.87%
Pretax Margin12.48%
Net Profit Margin12.44%
EBITDA Margin22.23%
EBIT Margin12.82%
Analyst Forecast
The average price target for EKF Diagnostics Holdings is £33.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target£33.50
Price Target Upside16.32% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-1.43%
EPS Growth Forecast28.57%